New Study Coming Soon!
Check back soon for more details.
(Not Currently Enrolling)
Biohaven Pharmaceuticals – Adults with Obsessive Compulsive Disorder
Obsessive Compulsive Disorder (OCD) is a mental health disorder that affects 1 in 100 people and occurs when a person gets caught in a cycle of obsessions and compulsions. Obsessions are unwanted, intrusive thoughts, images, or urges that trigger intensely distressing feelings. Compulsions are behaviors an individual engages in to attempt to get rid of the obsessions and/or decrease his or her distress.
There are medications used to treat OCD. However, some people do not experience relief from OCD symptoms despite being on medication. In this study, adults with OCD who are eligible to participate will receive an investigational medication that is taken in addition to their current medication. This investigational medication targets glutamate, a chemical in the brain that is believed to contribute to OCD. There is no cost to participate, and you may be compensated for your time and travel.
View more at: https://clinicaltrials.gov/ct2/show/NCT03299166